DD102410A5 - - Google Patents

Info

Publication number: DD102410A5
Authority: DD; German Democratic Republic

Application number

DD166879A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1971-11-17

Filing date

1972-11-15

Publication date

1973-12-12

1972-11-15 Application filed filed Critical

1973-12-12 Publication of DD102410A5 publication Critical patent/DD102410A5/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Gram-negative bacteria
- C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
- C07K16/1235—Salmonella (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Gram-negative bacteria
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Gram-negative bacteria
- C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Gram-negative bacteria
- C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
- C07K16/1232—Escherichia (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DD166879A 1971-11-17 1972-11-15 DD102410A5 (cs)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE2157148A DE2157148A1 (de)	1971-11-17	1971-11-17	Immunisierungsmittel, verfahren zur herstellung und seine verwendung

Publications (1)

Publication Number	Publication Date
DD102410A5 true DD102410A5 (cs)	1973-12-12

Family

ID=5825419

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD166879A DD102410A5 (cs)	1971-11-17	1972-11-15

Country Status (10)

Country	Link
JP (1)	JPS5512002B2 (cs)
AT (1)	AT332539B (cs)
BE (1)	BE791489A (cs)
CH (1)	CH588867A5 (cs)
DD (1)	DD102410A5 (cs)
DE (1)	DE2157148A1 (cs)
FR (1)	FR2160542B1 (cs)
GB (1)	GB1416544A (cs)
NL (1)	NL7215221A (cs)
SE (1)	SE406419B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3516119A1 (de) *	1985-05-04	1986-11-06	Biotest Pharma GmbH, 6000 Frankfurt	Polyvalentes hyperimmunglobulin-praeparat
DE10331974A1 (de) *	2003-07-14	2005-02-17	Uni-Klinikum Schleswig-Holstein Campus Kiel	Verfahren zur Herstellung und Verwendung antimikrobielle Proteine induzierender Faktoren
WO2014097154A1 (en) *	2012-12-20	2014-06-26	Zakład Badawczo-Wdrożeniowy Ośrodka Salmonella "Immunolab" Sp. Z O.O.	A polyvalent combined immunising and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, a method for production of this preparation, its use and a vaccine comprising this preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1468630A (fr) *	1963-03-14	1967-02-10	Taisho Pharmaceutical Co Ltd	Préparation du lipide alpha purifié à partir de lipide alpha brut dérivé des lipopolysaccharides de bactéries à gram-négatif

0
- BE BE791489D patent/BE791489A/xx unknown
1971
- 1971-11-17 DE DE2157148A patent/DE2157148A1/de not_active Ceased
1972
- 1972-11-07 CH CH1618372A patent/CH588867A5/xx not_active IP Right Cessation
- 1972-11-10 NL NL7215221A patent/NL7215221A/xx not_active Application Discontinuation
- 1972-11-10 SE SE7214629A patent/SE406419B/xx unknown
- 1972-11-14 GB GB5250272A patent/GB1416544A/en not_active Expired
- 1972-11-15 DD DD166879A patent/DD102410A5/xx unknown
- 1972-11-16 AT AT975872A patent/AT332539B/de not_active IP Right Cessation
- 1972-11-16 JP JP11431772A patent/JPS5512002B2/ja not_active Expired
- 1972-11-16 FR FR7240734A patent/FR2160542B1/fr not_active Expired

Also Published As

Publication number	Publication date
JPS5512002B2 (cs)	1980-03-29
DE2157148A1 (de)	1973-05-24
NL7215221A (cs)	1973-05-21
BE791489A (fr)	1973-05-16
AT332539B (de)	1976-10-11
FR2160542B1 (cs)	1976-04-23
GB1416544A (en)	1975-12-03
JPS4861621A (cs)	1973-08-29
FR2160542A1 (cs)	1973-06-29
CH588867A5 (cs)	1977-06-15
SE406419B (sv)	1979-02-12
AU4902772A (en)	1974-05-23
ATA975872A (de)	1976-01-15

Publication	Publication Date	Title
ATA136472A (cs)	1973-12-15
AR196074A1 (cs)	1973-11-30
FR2160542B1 (cs)	1976-04-23
AU2691671A (cs)	1972-09-28
AU2894671A (cs)	1972-11-23
AU3005371A (cs)	1972-12-21
AU2485671A (cs)	1972-08-03
AU2564071A (cs)	1972-08-24
AU2941471A (cs)	1972-11-30
AU2952271A (cs)	1972-12-07
AR202997Q (cs)	1975-08-08
AR192311Q (cs)	1973-02-14
AU2503871A (cs)	1972-08-10
AU2706571A (cs)	1971-07-15
AU2486471A (cs)	1972-08-03
AU2473671A (cs)	1972-08-03
AU2456871A (cs)	1972-08-17
AU3038671A (cs)	1973-01-04
AU3025871A (cs)	1973-01-04
AU2455871A (cs)	1972-07-27
AU2963771A (cs)	1972-12-07
AU2415871A (cs)	1972-07-13
AU2399971A (cs)	1972-07-06
AU2940971A (cs)	1972-11-30
AU2938071A (cs)	1972-11-30